Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision label on the Record History page updated from v3.6.6 to v3.7.0, signaling a new version of the page. This is a metadata update and does not modify the study data or its history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe history log now shows a new revision v3.6.6 added and the previous v3.6.5 removed, indicating a version update to the page.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history now shows Revision: v3.6.5, replacing the previous v3.6.4. This reflects a new build of the page's revision history rather than changes to the study data.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry (v3.6.4) was added to the study history, replacing the previous version (v3.6.3) and documenting an updated version of the record.SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry v3.6.3 is added to the study record history, replacing the previous v3.6.2, signaling an update to the page’s version for this study record.SummaryDifference0.1%

- Check96 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history. The earlier revision (v3.6.0) was removed from the visible history, updating the record's version history.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.